Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC

NCT07741448 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

UTUC

Interventions

DRUG: Trastuzumab Rezetecan
DRUG: Gemcitabine
PROCEDURE: Radical nephroureterectomy

Sponsor

Zhiquan Hu